Monroe Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Monroe Bank & Trust's BMY Position: Q3 2018 in Review
Monroe Bank & Trust sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 1,603 shares — an estimated $89K sold.
Monroe Bank & Trust first reported a position in BMY in Q2 2013 and held it in 18 quarters. The position peaked at $945K in Q1 2014. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.
- Monroe Bank & Trust reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
- Monroe Bank & Trust sold 1,603 Bristol-Myers Squibb shares in Q3 2018, an estimated $89K.
- Monroe Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 18 quarters.
- Monroe Bank & Trust's Bristol-Myers Squibb position peaked at $945K in Q1 2014.
- 1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.
Based on Monroe Bank & Trust's 13F filing for Q3 2018, filed 14 Nov 2018.